We offer ready-to-use probe and primer sets that enable confident and scalable SARS-CoV-2 testing.

We safeguard the integrity of your COVID-19 workflows by manufacturing and shipping oligos in a completely separate and geographically distant facility from positive control production.

We’re the inventor and original source of all the quenching technologies that are cited in the protocols published by WHO

You can rely on our secure, vertically integrated supply chain which allows us to manufacture oligos quickly and at scale

Move quickly with a ready-to-use, out-of-the-box solution for high complexity CLIA labs running the CDC EUA protocol. 

• 

  2019-nCoV CDC-qualified Probe and Primer Kits for SARS-CoV-2

Pick and choose which COVID-19 signatures work best for your lab with individual RUO probes and primers using sequences as designated by Charité and US CDC protocols:

• 

  Charité 2019-nCoV BBQ-650 ValuPanel Reagents

• 

  Charité 2019-nCoV BHQ ValuPanel Reagents

• 

  US CDC 2019-nCoV ValuPanel Reagents

Request probes of your own design using the BHQ technology we invented:

• 

  See all DNA probe formats

LGC SeraCare offer a complete Quality Solution for COVID-19 diagnostic assay validation

AccuPlex™ technology mimics wild-type pathogenic viruses, but is safe, non-infectious, and replication deficient. These materials serve as true, full-process quality solutions that challenge the entire diagnostic workflow, making them the preferred alternative to infectious materials.

Together, the AccuPlex SARS-CoV-2 Verification Panel and AccuPlex SARS-CoV-2 Reference Material Kit offer an ideal solution for clinical laboratories looking for a safe, effective tool to verify and monitor SARS-CoV-2 molecular assay performance. Products contain positive materials directed against the published CDC and WHO consensus sequences and the S gene. Negative materials targeting the human RNase P gene are also included.

“We just went ‘live’ with the SARS-CoV-2 assay…I’ve never brought in and validated an assay in 7 days. The LGC SeraCare reference material works perfectly. I needed something other than the assay’s positive control to create a positive assay result before I felt comfortable releasing the assay for patient testing, and your product did the trick.”

Medical Director, Clinical Chemistry Laboratory prominent Boston Academic Medical Hospital

For testing

LGC, Biosearch Technologies' oKtopure™ and IntelliQube™ instrumentation can alleviate sample preparation and testing bottlenecks with ultra-high-throughput instrumentation that was originally developed for the leaders in seed genetics. While these instruments are RUO, they are increasingly being used in CLIA labs as they offer far greater throughput for both nucleic acid extraction and qPCR-based detection than any other instrumentation on the market.

Designed for genetic target testing of millions of samples per year.

Automation and reliability enables day-in and day-out operation with minimal human intervention.

Significantly increase your ability to ramp up testing capacity and speed.

A single oktopure/IntelliQube combination can provide ~2000 sample. extractions and tests per 8-hour period depending on assay and process setup.

• 

  oKtopure

  A high throughput nucleic acid purification system that produces high-purity RNA for testing. The system performs lysis, extraction, and purification on eight 96-well plates at a time using sbeadex viral RNA magnetic beads and buffer kits.

• 

  IntelliQube qPCR System

  A highly automated qPCR system that integrates liquid handling, plate sealing, thermal cycling and multiplexed reading.The IntelliQube performs automated sample mixing and qPCR detection on continuous feed Array Tape, which eliminates the need for well plates, reduces reaction volume and reagent use, and allows for continuous operation without frequent intervention. The system is ideal for highly batched, high throughput testing scenarios where consistent performance, high test volume, and low cost per reaction are important.